Correlation Between Israel China and Nextage Therapeutics

Can any of the company-specific risk be diversified away by investing in both Israel China and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Israel China Biotechnology and Nextage Therapeutics, you can compare the effects of market volatilities on Israel China and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Nextage Therapeutics.

Diversification Opportunities for Israel China and Nextage Therapeutics

-0.58

Correlation Coefficient

Israel China  Nextage Therapeutics

Excellent diversification

The 3 months correlation between Israel and Nextage is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Israel China i.e., Israel China and Nextage Therapeutics go up and down completely randomly.

Pair Corralation between Israel China and Nextage Therapeutics

Assuming the 90 days trading horizon Israel China Biotechnology is expected to under-perform the Nextage Therapeutics. In addition to that, Israel China is 1.26 times more volatile than Nextage Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Nextage Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  8,530  in Nextage Therapeutics on December 30, 2024 and sell it today you would earn a total of  930.00  from holding Nextage Therapeutics or generate 10.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Israel China Biotechnology  vs.  Nextage Therapeutics

Israel China Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Israel China Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Nextage Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Israel China and Nextage Therapeutics

The main advantage of trading using opposite Israel China and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.

The idea behind Israel China Biotechnology and Nextage Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.